Why the study?
Does a new Doppler index of systolic and diastolic myocardial performance (SDMP) improve the assessment of right-ventricular impairment in patients with chronic respiratory failure compared to healthy subjects?
Does a new Doppler index of systolic and diastolic myocardial performance (SDMP) improve the assessment of right-ventricular impairment in patients with chronic respiratory failure compared to healthy subjects?
A newly defined Doppler index (SDMP) effectively distinguishes right-ventricular impairment in patients with chronic respiratory failure from healthy subjects without overlap.
May aid noninvasive RV assessment in respiratory failure; leaves open prospective validation before clinical adoption.
We evaluated the usefulness of the newly defined Doppler index combining systolic and diastolic myocardial performance, in assessing right-heart dysfunction in 29 patients with chronic respiratory failure caused by old tuberculosis who were on 24-h home oxygen therapy. We measured tricuspid inflow velocity, right-ventricular outflow velocity, late/early diastolic peak velocities (A/E), the ratio between pre-ejection period and ejection time (PEP/ET), and the new index of systolic and diastolic myocardial performance (SDMP) calculated as (isovolumetric contraction time + isovolumetric relaxation time)/ejection time. The calculated A/E, PEP/ET and SDMP in our patients were significantly higher than those in age-matched healthy subjects (n = 37, mean age 67 +/- 8 years). There was no overlap in the SDMP index between healthy subjects and patients and the index was not influenced by heart rate. Our results suggest that SDMP index is a better marker than A/E and PEP/ET for the assessment of right-ventricular impairment.
No takes yet. Share an insight, caveat, or question.
Yamaguchi et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: